Intel·Sports Nutrition
Open Season
EU law gives creatine brands exactly one authorized health claim. US brands face no such guardrail. Here's how American advertisers are spending that freedom — and what the trust gap looks like.
Key takeaways
- →US creatine brands face no pre-approved claim list — DSHEA allows structure/function claims with only a boilerplate FDA disclaimer
- →Cognitive claims (brain fog, mental clarity, focus) dominate US Meta creative; they're off-limits under EU/UK authorized claim rules
- →Gummies are the primary DTC growth format — not a niche; multiple brands running multi-creative campaigns at scale
- →Women are the expansion audience, segmented by life stage: gym-goers, new mothers, perimenopause, and identity-led sub-brands
- →Third-party lab testing has become a standard trust signal — brands using it offensively against competitors who under-dose
- →Creapure® from Bavaria appears in US premium positioning too, but framed around purity rather than regulatory compliance
Earlier today we mapped how EU and UK creatine brands operate inside a tight regulatory box: one EFSA-authorized claim, strict dose requirements, and an ASA willing to enforce. The US market is a different game entirely.
Under DSHEA — the Dietary Supplement Health and Education Act — brands can make structure/function claims without FDA pre-approval. They just need a disclaimer: “These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” That's it. The result on Meta right now is a creatine market saying almost anything it wants — and competing hard on what it says.
The gummy gold rush
The most active segment in US creatine Meta creative right now is gummies. Not a niche — a primary format with multiple brands running multi-creative campaigns at scale. OMNI Creatine, Crave Creatine, SWOLY, Tasty Gains, and Bear Balanced are all live with gummy-focused campaigns, and the creative playbooks are strikingly similar: convenience, taste, and consistency framing.
SWOLY Supplements — Active
SWOLY: The Tastiest Creatine Boost
'Fuel your workouts and enjoy your daily dose of creatine with our convenient and delicious gummies. Packed with goodness, they make supplementing feel like a treat. It's time to make your fitness journey more enjoyable!' — getswoly.com
Omni Creatine — Active
Creatine Made Delicious 🍉 🍑
'Third-party tested and proven to pack pure creatine monohydrate to boost energy, mental clarity and lean muscle — without any bloating or puffiness. Get 47% OFF + FREE Shipping.' — omnicreatine.com
The format bet is clear: powders require daily intention. Gummies lower the activation energy for a habit that, at 5g/day, runs indefinitely. The creative leans into that — “makes supplementing feel like a treat,” “something people actually want to take consistently.” Retention, not just acquisition, is the product design.
EU brands have creatine gummies too — ESN launched theirs this year — but the Meta spend behind gummies in the US dwarfs what's visible in European markets. The format is roughly two years further along in the DTC lifecycle.
Brain claims, unlocked
This is where US creative diverges most sharply from EU. The science on creatine and cognitive function is real — ATP replenishment supports brain energy, particularly under stress or sleep deprivation — but no cognitive benefit has been authorized under EFSA Regulation 432/2012. EU brands making these claims risk ASA enforcement. US brands put them in the headline.
OMNI Longevity — Active
Real Creatine — 43% OFF TODAY
Benefits listed: 'Builds lean muscle, without the bulk or bloat / More daily energy and endurance / Sharper focus and less afternoon brain fog / Deeper, more restful sleep / Faster recovery so you bounce back quicker'
Xendurance — Active
Creatine-JB — Certified Sport + Performance
'Adequate creatine stores in the brain allow for optimal energy production to support brain and cognitive function. Creatine-JB promotes increased energy and strength.' — formulated with Creapure® from Germany
Notably, Xendurance carries the Creapure® mark from AlzChem Bavaria — the same German ingredient EU brands use as a quality signal — but pairs it with cognitive claims no EU brand running Creapure® could make. The ingredient crosses the Atlantic; the regulatory environment doesn't.
AG1 by Athletic Greens is taking a different angle: their current Meta campaign highlights Creavitalis® creatine monohydrate as part of a “daily nutrition plus advanced muscle and gut support” stack. Creatine as a daily longevity ingredient, not a sports supplement. That positioning — while legally available in the US — would require careful claim mapping to survive EU scrutiny.
Who's buying creatine now
The most significant creative shift in US creatine advertising right now is not format or claim — it's audience. Creatine has historically been positioned for male gym-goers. The active Meta campaigns suggest that market is being deliberately left behind in favor of women.
1st Phorm — Active
I Was Wrong About Creatine Being 'Not For Me'
Female-voiced testimonial: 'I spent way too long assuming creatine was a gym bro thing, not something a woman with my goals needed. Two years in, I'm lifting heavier, recovering better, and honestly the mental sharpness caught me off guard the most.'
OMNI Longevity — Active
Feel Like Yourself Again
Postpartum-targeted: '8 weeks postpartum, 2 kids under 2. My brain was foggy, my energy was gone, and I needed something that actually helped.' — frames creatine as recovery, not performance
Needed. goes further still: their Women's Creatine campaign targets longevity and life-stage resilience (“support for every life stage”), listing benefits as lean muscle, brain energy, cognitive resilience, and fatigue reduction — a product and messaging architecture EU brands simply cannot replicate without claim-by-claim authorization.
Black Girl Vitamins is running a new-product launch for their creatine powder with “cognitive stamina” and “explosive strength” front and center. Sub-brand audience targeting — splitting the women's market further by community — is happening at the creative level, not just media targeting.
The trust gap
Without regulatory pre-approval as a default quality floor, the US market has built its own trust signals. Third-party lab testing has moved from a quiet safety measure to a front-line creative weapon — and some brands are deploying it offensively.
OMNI Longevity — Active (editorial-style)
Most Popular Creatine Gummies RANKED
Run via a PA-C influencer account: 'An independent lab tested 6 of the bestselling creatine gummies. 4 of them had little to no real creatine inside. Some were almost zero.' Positioned as a third-party ranking — links to OMNI.
Crave Creatine — Active
★★★★★ 4.7/5 Star Rating
'Other creatine gummies? They say 5g… but lab tests say otherwise. We test every batch to guarantee full potency — and insane flavor.' Proudly made in the USA.
The attack pattern is consistent: competitor gummies are candy; ours are tested. It's a meaningful claim in a market with no mandatory dosing verification, and it's being amplified via editorial-style creative (influencer accounts framed as independent reviewers) that keeps the brand one step removed from the attack.
Six Star takes a different route: citing a clinical study directly in ad copy. “In a 12-week study on untrained individuals, subjects taking the creatine in Six Star Creatine products gained over four times more muscle than subjects using a placebo (7.12 vs. 1.30 lbs.).” Walmart shelf placement, scientific framing, direct efficacy numbers — mass-market trust-building without the lab-testing creative arms race.
What the data signals
Gummies are the primary DTC battleground, not a sub-segment
Multiple brands running parallel gummy campaigns with nearly identical creative angles (convenience, taste, habit-stacking) means differentiation will increasingly come from trust signals and audience specificity — not format novelty. The format wars are already over.
Cognitive claims are the default — not an edge case
Brain fog, mental clarity, and focus appear across brands at every price point. This is where US creative most visibly outpaces what EU brands can say. Any EU brand planning US expansion will face a creative recalibration problem: their compliant EU copy underperforms against US-native creative.
Women's life-stage segmentation is market structure forming, not a trend
Postpartum recovery, perimenopause resilience, and identity-community targeting show this isn't a single women's pivot — it's segmentation in progress. Brands that get specific early will have audience ownership. Brands that pivot generically will lose it.
Lab-testing creative is filling the regulatory gap — and escalating
Third-party testing has moved from compliance to positioning to attack vector. The editorial-style influencer campaigns (independent ranking content that links back to the brand) suggest some players are building entire campaign architectures around the trust gap. Expect this to get louder before it gets regulated.
Related intelligence
How European brands build around EFSA's single authorized creatine claim — and where the grey zone starts.
The authorized claim landscape for greens formulas across EU and UK markets.
Run your own
Want this kind of breakdown on your own competitor set? Snapshots pull any brand’s active Meta ads and structure the data for you.
See how Snapshots work →